ANDA 74403, held by Hospira. Dopamine Hydrochloride.
As of Nov 16, 2026, ANDA 74403 (Dopamine Hydrochloride), held by Hospira, was first approved by FDA on May 23, 1996, with 1 approved supplement and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| May 23, 1996 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Dopamine Hydrochloride40MG/ML ยท injectable;injection | Dopamine Hydrochloride | Discontinued |
| Feb 14, 2001 | Supplement 1Manufacturing | Approved | None posted |
| May 23, 1996 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters